Prestige Consumer Healthcare Inc. Expands CFO Christine Sacco’s Role to Include Chief Operating Officer Responsibilities

PBH 01.06.2025

Full Press ReleaseSEC FilingsOur PBH Tweets

About Gravity Analytica

Recent News

  • 02.06.2025 - Q3 2025 Prestige Consumer Healthcare Inc. Earnings Conference Call
  • 01.14.2025 - ICR 2025 Conference Presentation
  • 01.09.2025 - Prestige Consumer Healthcare Announces Fiscal 2025 Third Quarter Earnings Results Date and ICR Conference Presentation

Recent Filings

  • 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.06.2025 - 8-K Current report
  • 01.06.2025 - EX-99.1 EX-99.1
PDF Version

TARRYTOWN, N.Y.,Jan. 06, 2025(GLOBE NEWSWIRE) --Prestige Consumer Healthcare Inc.(the “Company” or “Prestige”) (NYSE: PBH) today announced that Chief Financial OfficerChristine Sacco’sresponsibilities have been expanded to include the role of Chief Operating Officer, effective immediately. In this enhanced position as COO/CFO,Ms. Saccowill oversee the Company’s supply chain, in addition to her existing responsibilities.Ms. Saccowill continue to report toRon Lombardi, Chief Executive Officer of Prestige.

“Chris’ strategic leadership and deep understanding of our business has been instrumental in our growth and success over her 8 years as CFO,” saidRon Lombardi. “This expanded COO/CFO role positions us to further enhance execution of our strategic initiatives and drive operational excellence across the organization. Her proven track record in finance combined with her experience working closely with our supply chain operations uniquely positions her to drive further operational excellence and long-term organic and M&A growth for our Company in this expanded role.”

A seasoned executive with more than 27 years of leadership experience in the consumer products and specialty pharma space,Ms. Saccohas served as the Company’s Chief Financial Officer since 2016. During her tenure, she has made vital contributions to the Company’s strategic transformation and financial success. Under her financial leadership, the Company has achieved strong sales, earnings and cash flow growth over the past 8 years while positioning Prestige with significant future capital allocation flexibility to drive further shareholder value.

AboutPrestige Consumer Healthcare Inc.

Prestige Consumer Healthcareis a leading consumer healthcare products company with sales throughout theU.S.andCanada,Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat®and Summer’s Eve®women's health products, BC®and Goody's®pain relievers, Clear Eyes®and TheraTears®eye care products, DenTek®specialty oral care products, Dramamine®motion sickness treatments, Fleet®enemas and glycerin suppositories, Chloraseptic®and Luden's®sore throat treatments and drops, Compound W®wart treatments, Little Remedies®pediatric over-the-counter products, Boudreaux’s Butt Paste®diaper rash ointments, Nix®lice treatment, Debrox®earwax remover, Gaviscon®antacid inCanada, and Hydralyte®rehydration products and the Fess®line of nasal and sinus care products inAustralia. Visit the Company's website atwww.prestigeconsumerhealthcare.com.

Investor Relations Contact

Phil Terpolilli, CFA, 914-524-6819irinquiries@prestigebrands.com

Source:Prestige Consumer Healthcare Inc.

A photo accompanying this announcement is available athttps://www.globenewswire.com/NewsRoom/AttachmentNg/b8a99b5b-fd18-4d27-9a39-e14d1986df82

Primary Logo

Christine Sacco

Christine Sacco, CFO and COO ofPrestige Consumer Healthcare Inc.

Source: Prestige Consumer Healthcare Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com